MediWound Ltd. (MDWD)
MediWound Statistics
Share Statistics
MediWound has 10.81M shares outstanding. The number of shares has increased by 21.2% in one year.
| Shares Outstanding | 10.81M |
| Shares Change (YoY) | 21.2% |
| Shares Change (QoQ) | 4.31% |
| Owned by Institutions (%) | 41.09% |
| Shares Floating | 7.25M |
| Failed to Deliver (FTD) Shares | 539 |
| FTD / Avg. Volume | 0.7% |
Short Selling Information
The latest short interest is 1.01M, so 8.94% of the outstanding shares have been sold short.
| Short Interest | 1.01M |
| Short % of Shares Out | 8.94% |
| Short % of Float | 10.43% |
| Short Ratio (days to cover) | 10.35 |
Valuation Ratios
The PE ratio is -5.87 and the forward PE ratio is -7.76. MediWound's PEG ratio is -0.02.
| PE Ratio | -5.87 |
| Forward PE | -7.76 |
| PS Ratio | 8.77 |
| Forward PS | 1.4 |
| PB Ratio | 5.69 |
| P/FCF Ratio | -8.91 |
| PEG Ratio | -0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MediWound.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.97 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | -0.23 |
| Debt / FCF | -0.33 |
| Interest Coverage | -25.8 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $182.18K |
| Profits Per Employee | $-272.29K |
| Employee Count | 111 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 6.53 |
Taxes
| Income Tax | 61K |
| Effective Tax Rate | -0.2% |
Stock Price Statistics
The stock price has increased by -1.21% in the last 52 weeks. The beta is 0.5, so MediWound's price volatility has been higher than the market average.
| Beta | 0.5 |
| 52-Week Price Change | -1.21% |
| 50-Day Moving Average | 17.02 |
| 200-Day Moving Average | 17.69 |
| Relative Strength Index (RSI) | 60.27 |
| Average Volume (20 Days) | 76.81K |
Income Statement
In the last 12 months, MediWound had revenue of 20.22M and earned -30.22M in profits. Earnings per share was -3.03.
| Revenue | 20.22M |
| Gross Profit | 2.63M |
| Operating Income | -19.4M |
| Net Income | -30.22M |
| EBITDA | -27.93M |
| EBIT | -29.41M |
| Earnings Per Share (EPS) | -3.03 |
Balance Sheet
The company has 9.15M in cash and 6.51M in debt, giving a net cash position of 2.64M.
| Cash & Cash Equivalents | 9.15M |
| Total Debt | 6.51M |
| Net Cash | 2.64M |
| Retained Earnings | -205.05M |
| Total Assets | 73.5M |
| Working Capital | 25.62M |
Cash Flow
In the last 12 months, operating cash flow was -13.62M and capital expenditures -6.27M, giving a free cash flow of -19.9M.
| Operating Cash Flow | -13.62M |
| Capital Expenditures | -6.27M |
| Free Cash Flow | -19.9M |
| FCF Per Share | -2 |
Margins
Gross margin is 13.03%, with operating and profit margins of -95.94% and -149.46%.
| Gross Margin | 13.03% |
| Operating Margin | -95.94% |
| Pretax Margin | -149.16% |
| Profit Margin | -149.46% |
| EBITDA Margin | -138.11% |
| EBIT Margin | -95.94% |
| FCF Margin | -98.39% |
Dividends & Yields
MDWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MDWD is $32, which is 77.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $32 |
| Price Target Difference | 77.6% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Dec 20, 2022. It was a backward split with a ratio of 1:7.
| Last Split Date | Dec 20, 2022 |
| Split Type | backward |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | -1.77 |
| Piotroski F-Score | 3 |